0000899243-21-000692.txt : 20210106
0000899243-21-000692.hdr.sgml : 20210106
20210106162828
ACCESSION NUMBER: 0000899243-21-000692
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Cynthia
CENTRAL INDEX KEY: 0001609480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38266
FILM NUMBER: 21510953
MAIL ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701108
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-242-1600
MAIL ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Spero Therapeutics, LLC
DATE OF NAME CHANGE: 20170316
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001701108
Spero Therapeutics, Inc.
SPRO
0001609480
Smith Cynthia
C/O SPERO THERAPEUTICS, INC.
675 MASSACHUSETTS AVENUE, 14TH FLOOR
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
17.93
2021-01-04
4
A
0
2629
13.31
A
2031-01-04
Common Stock
2629
2629
D
This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $35,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.
/s/ Cynthia Smith
2021-01-06